A Clinico-Radiological Study of Cerebral Amyloid Angiopathy-Related Inflammation.


Journal

Cerebrovascular diseases (Basel, Switzerland)
ISSN: 1421-9786
Titre abrégé: Cerebrovasc Dis
Pays: Switzerland
ID NLM: 9100851

Informations de publication

Date de publication:
2019
Historique:
received: 28 01 2019
accepted: 20 08 2019
pubmed: 25 9 2019
medline: 12 5 2020
entrez: 25 9 2019
Statut: ppublish

Résumé

To describe the clinico-radiological features and long-term prognosis in patients with cerebral amyloid angiopathy-related inflammation (CAA-ri). Twenty-eight CAA-ri patients were recruited retrospectively from 6 neurological centers. We recorded the clinico-radiological and biological data, at baseline and during follow-up. Baseline characteristics associated with relapse risk and prognosis were assessed. Five patients had pathologically confirmed CAA-ri whereas 23 had probable (n = 21) or possible (n = 2) CAA-ri. The mean age was 72 years; main clinical symptoms included confusion (54%), hemiparesis (36%), and aphasia (29%). Cerebral MRI disclosed a brain parenchymal lesion (89%), which was usually multifocal (82%) and bilateral (89%). It was associated with gadolinium enhancement (84%), small ischemic lesions (39%), cortical superficial siderosis (CSS; 50%), and a high number of microbleeds (mean 240 ± 277). An isolated leptomeningeal involvement was observed in 3 patients with pathological confirmation. Despite a favorable initial evolution after treatment, we observed a 42% risk of relapse, mostly within the first year (83%). After a mean follow-up of 2 years, 29% died and 25% had a marked disability. Disseminated CSS was associated with death. Despite an apparently favorable initial evolution, CAA-ri is characterized by a poor prognosis. Diagnostic criteria should consider patients with isolated leptomeningeal involvement.

Identifiants

pubmed: 31550722
pii: 000502832
doi: 10.1159/000502832
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-44

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Sarah Coulette (S)

Department of Neurology, Montpellier University Hospital, Montpellier, France.

Dimitri Renard (D)

Department of Neurology, Nimes University Hospital, Nimes, France.

Sylvain Lehmann (S)

IRMB, CRB, Inserm U11183, Montpellier University Hospital, Montpellier, France.

Nicolas Raposo (N)

Department of Neurology, Toulouse University Hospital, Toulouse, France.

Caroline Arquizan (C)

Department of Neurology, Montpellier University Hospital, Montpellier, France.

Mahmoud Charif (M)

Department of Neurology, Montpellier University Hospital, Montpellier, France.

Eric Thouvenot (E)

Department of Neurology, Nimes University Hospital, Nimes, France.

Anne Wacongne (A)

Department of Neurology, Nimes University Hospital, Nimes, France.

Alain Viguier (A)

Department of Neurology, Toulouse University Hospital, Toulouse, France.

Fabrice Bonneville (F)

Department of Neuroradiology, Toulouse University Hospital, Toulouse, France.

Thibaut Allou (T)

Department of Neurology, Perpignan Hospital, Perpignan, France.

Yassine Boukriche (Y)

Department of Neurology, Beziers Hospital, Beziers, France.

Laura Chiper (L)

Department of Neurology, Beziers Hospital, Beziers, France.

Genevieve Blanchet Fourcade (G)

Department of Neurology, Narbonne Hospital, Narbonne, France.

Audrey Gabelle (A)

Department of Neurology, Montpellier University Hospital, Montpellier, France.
Memory Research and Resources Center, Montpellier University Hospital, Montpellier, France.

Anne Ducros (A)

Department of Neurology, Montpellier University Hospital, Montpellier, France.

Claire Duflos (C)

Economic Evaluation Unit, Montpellier University Hospital, Montpellier, France.

Pierre Labauge (P)

Department of Neurology, Montpellier University Hospital, Montpellier, France.

Nicolas Menjot de Champfleur (N)

Neuroradiology, Montpellier University Hospital, Montpellier, France.

Xavier Ayrignac (X)

Department of Neurology, Montpellier University Hospital, Montpellier, France, xavier.ayrignac@yahoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH